StockDriftsStockDriftsTop 3 Mayo Clinic Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ACWI | ISHARES TR | 71.52% | 17.4K | $2.1M | +0.00%(+0) | — | 2024-09-30 | |
| ZNTL | Zentalis Pharmaceuticals Inc | 22.19% | 175.0K | $644K | -6.49%(-12.14K) | — | 2024-09-30 | |
| UNBX | UNITY BIOTECHNOLOGY INC | 6.29% | 124.1K | $182K | +0.00%(+0) | — | 2024-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Mayo Clinic reports $2.90M in US-listed equity holdings across 3 positions in its most recent 13F filing. Its largest disclosed positions are ACWI (71.5%), ZNTL (22.2%) and UNBX (6.3%). Figures reflect the Q3 2024 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Mayo Clinic, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Mayo Clinic’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1318153). View Mayo Clinic’s 13F filings on SEC